Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 215
Filtrar
Mais filtros

Intervalo de ano de publicação
1.
PLoS One ; 17(3): e0266080, 2022.
Artigo em Inglês | MEDLINE | ID: mdl-35353869

RESUMO

In a Box-Behnken assessment of elevated branched-chain amino acids (BCAA), 13 nutritionally equivalent maize-based diets were offered to a total of 390 off-sex male Ross 308 broiler chickens from 7 to 28 days post-hatch. The BCAA concentrations investigated in reduced-crude protein diets were 12.5, 15.5, 18.3 g/kg leucine (125, 155, 183); 8.9, 10.2, 12.5 g/kg valine (89, 102, 125) and 7.2, 8.9, 10.8 g/kg isoleucine (72, 89, 109), where their relativity to 11.0 g/kg digestible lysine are shown in parentheses. Determined parameters included growth performance, relative abdominal fat-pad weights, nutrient utilisation, apparent digestibility coefficients, disappearance rates of 16 amino acids and free amino acid systemic plasma concentrations. Increasing dietary leucine linearly depressed weight gain and quadratically influenced FCR where the estimated minimum FCR of 1.418 was with 14.99 g/kg leucine. Polynomial regression analysis and surface response curves of determined parameters were generated for significant (P < 0.05) BCAA variables, based on lack of fit (P > 0.005). Quadratic and cross-product responses were observed for weight gain, FCR, AME, AMEn, N retention and apparent digestibility of 13 amino acids. Relative fat-pad weights declined linearly with increasing isoleucine and valine. The lowest N retention was estimated at a combination of 15.25 and 10.50 g/kg leucine and valine respectively whilst the highest mean digestibility coefficient (0.793) of amino acids was estimated at a combination of 15.74 and 10.47 g/kg of leucine and valine respectively. The remaining parameter minima or maxima responses were not able to be determined since they were outside the extreme BCAA treatment levels. Increasing dietary BCAA significantly increased apparent ileal digestibilities and disappearance rates of BCAA. Systemic plasma concentrations of valine increased (P < 0.001) with increasing dietary valine but leucine was not influenced (P > 0.25). Systemic plasma concentration of isoleucine was maximised (P < 0.001) only when accompanied by elevated dietary leucine. Also, dietary treatments influenced (P < 0.05) apparent disappearance rates of all the essential amino acids analysed, with the exception of methionine. Whilst overall growth performance was not disadvantaged (P > 0.10) by elevated BCAA levels, compared with 2019 Ross 308 performance objectives, polynomial regression analysis suggested both interaction and antagonism between BCAA.


Assuntos
Galinhas , Isoleucina , Aminoácidos/metabolismo , Aminoácidos de Cadeia Ramificada , Ração Animal/análise , Animais , Dieta/veterinária , Dieta com Restrição de Proteínas , Leucina , Masculino , Valina , Aumento de Peso/fisiologia
2.
Obesity (Silver Spring) ; 30(3): 639-644, 2022 03.
Artigo em Inglês | MEDLINE | ID: mdl-35166035

RESUMO

OBJECTIVE: Weight change is a dynamic function of whole-body energy balance resulting from the interplay between energy intake and energy expenditure (EE). Recent reports have provided evidence for the existence of a causal effect of EE on energy intake, suggesting that increased EE may drive overeating, thereby promoting future weight gain. This study investigated the relationships between ad libitum energy intake and 24-hour EE (24-h EE) in sedentary conditions versus long-term, free-living weight change using a mediation analysis framework. METHODS: Native American individuals (n = 61, body fat by dual-energy x-ray absorptiometry: 39.7% [SD 9.5%]) were admitted to the clinical inpatient unit and had baseline measurements as follows: 1) 24-h EE accurately measured in a whole-room indirect calorimeter during energy balance and weight stability; and 2) ad libitum energy intake objectively assessed for 3 days using computerized vending machines. Free-living weight change was assessed after a median follow-up time of 1.7 years (interquartile range: 1.2-2.9). RESULTS: The total effect of 24-h EE on weight change (-0.23 kg per 100-kcal/d difference in EE at baseline) could be partitioned into the following two independent and counterbalanced effects: higher EE protective against weight gain (-0.46 kg per 100-kcal/d difference in EE at baseline) and an orexigenic effect promoting overeating, thereby favoring weight gain (+0.23 kg per 100-kcal/d difference in EE at baseline). CONCLUSIONS: The overall impact of EE on body weight regulation should be evaluated by also considering its collateral effect on energy intake. Any weight loss intervention aimed to induce energy deficits by increasing EE should take into account any potential orexigenic effects that promote compensatory overeating, thereby limiting the efficacy of these obesity therapies.


Assuntos
Composição Corporal , Metabolismo Energético , Composição Corporal/fisiologia , Peso Corporal/fisiologia , Ingestão de Energia/fisiologia , Metabolismo Energético/fisiologia , Humanos , Hiperfagia , Aumento de Peso/fisiologia
3.
Nat Commun ; 13(1): 99, 2022 01 10.
Artigo em Inglês | MEDLINE | ID: mdl-35013190

RESUMO

Low total energy expenditure (TEE, MJ/d) has been a hypothesized risk factor for weight gain, but repeatability of TEE, a critical variable in longitudinal studies of energy balance, is understudied. We examine repeated doubly labeled water (DLW) measurements of TEE in 348 adults and 47 children from the IAEA DLW Database (mean ± SD time interval: 1.9 ± 2.9 y) to assess repeatability of TEE, and to examine if TEE adjusted for age, sex, fat-free mass, and fat mass is associated with changes in weight or body composition. Here, we report that repeatability of TEE is high for adults, but not children. Bivariate Bayesian mixed models show no among or within-individual correlation between body composition (fat mass or percentage) and unadjusted TEE in adults. For adults aged 20-60 y (N = 267; time interval: 7.4 ± 12.2 weeks), increases in adjusted TEE are associated with weight gain but not with changes in body composition; results are similar for subjects with intervals >4 weeks (N = 53; 29.1 ± 12.8 weeks). This suggests low TEE is not a risk factor for, and high TEE is not protective against, weight or body fat gain over the time intervals tested.


Assuntos
Tecido Adiposo/metabolismo , Composição Corporal/fisiologia , Metabolismo Energético/fisiologia , Água/metabolismo , Adulto , Teorema de Bayes , Criança , Bases de Dados Factuais , Feminino , Humanos , Marcação por Isótopo , Estudos Longitudinais , Masculino , Pessoa de Meia-Idade , Aumento de Peso/fisiologia
4.
Surg Obes Relat Dis ; 17(12): 2015-2025, 2021 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-34635422

RESUMO

BACKGROUND: Weight regain (WR) has been an emerging problem after Roux-en Y gastric bypass (RYGB) and little is known about the mechanisms of WR after RYGB. OBJECTIVE: To evaluate the mechanisms of WR after RYGB through the postprandial gut hormones response, particularly glucagon-like peptide-1 (GLP-1), which regulates appetite control, energy expenditure, body composition, physical activities, dietary intake, and psychological factors. SETTING: Duke University Medical Center, Durham, North Carolina. METHODS: A cross sectional study of 34 patients who underwent RYGB at least 2 years and achieved ≥50% of excess weight loss at 1year was conducted. The subjects were categorized into WR group or sustained weight loss group, based upon whether their WR was ≥15% of postoperative lowest weight. RESULTS: The WR group had less augmented postprandial GLP-1 response but exaggerated hyperinsulinemia. Postprandial peptide YY, ghrelin, and glucose were not different between group. Patients who regained weight required less weight-adjusted energy expenditure and had more percentage body fat and less percentage lean mass. The caloric intake and diet composition were comparable between groups; however, the WR group had higher depression scores, binge eating scales, and hunger rating and spent significantly less time on vigorous exercise. CONCLUSIONS: The mechanisms of WR in patients who were initially successful after RYGB are complex and involved not only the role of postprandial gut hormone response but are also related to energy expenditure adaptation and body composition changes. Moreover, food preference and physical activity may play roles in weight control after bariatric surgery. Further prospective controlled trial is needed to explore the mechanisms of WR.


Assuntos
Derivação Gástrica , Composição Corporal , Estudos Transversais , Metabolismo Energético , Humanos , Metaboloma , Aumento de Peso/fisiologia , Redução de Peso/fisiologia
5.
Prog Transplant ; 30(4): 322-328, 2020 12.
Artigo em Inglês | MEDLINE | ID: mdl-32930038

RESUMO

BACKGROUND: Weight gain after kidney transplantation is a common health problem. The factors in weight gain after kidney transplant include many factors such as age, ethnicity, gender, change in lifestyle (eg, kilocalorie intake and physical activity level), and immunosuppressive therapy. RESEARCH QUESTIONS: This study aimed to evaluate the relationship between weight gain and energy intake in dietary, energy expenditure in physical activity, and immunosuppressive therapy in kidney transplant recipients. DESIGN: This prospective, observational study included 51 participants who underwent kidney transplant, during 6 months from the start of the study. Anthropometric measurements were performed at first week, third- and sixth-month follow-ups of transplant recipients. Participants also completed 3-day "Dietary Record Form" and the "Physical Activity Record Form" at each follow-up. Simple frequency, analysis of variance analysis, and correlation analysis were used for data analysis. RESULTS: Weight gain in sixth month follow-up compared to baseline value was positively related to energy intake in first week (r = 0.59), third month (r = 0.75), and sixth month (r = 0.67) follow-ups, and energy expenditure in first week (r = 0.35) and sixth month (r = 0.34) follow-ups. However, weight gain was negatively related to mycophenolate mofetil dose (mg/d) in sixth month (r = -0.31) follow-up (P < .05). DISCUSSION: The results of this study provide an opportunity to reflect and discuss on modifiable risk factors such as energy intake and energy expenditure that affect weight gain posttransplantation in participants. It also examines the relationship between immunosuppressive therapy. Additionally, these results can be effective in designing interventions and managing risk factors to achieve weight management goals.


Assuntos
Ingestão de Energia/fisiologia , Metabolismo Energético/fisiologia , Exercício Físico/fisiologia , Transplante de Rim/reabilitação , Transplantados/psicologia , Condicionamento Pré-Transplante/efeitos adversos , Aumento de Peso/fisiologia , Adulto , Feminino , Seguimentos , Humanos , Terapia de Imunossupressão , Masculino , Pessoa de Meia-Idade , Estudos Prospectivos , Fatores de Risco , Turquia
6.
PLoS One ; 15(6): e0233416, 2020.
Artigo em Inglês | MEDLINE | ID: mdl-32502147

RESUMO

OBJECTIVE: To determine whether neighbourhood socioeconomic status (SES) was associated with large for gestational age (LGA) while considering key sociodemographic and clinical confounding factors. SETTING AND PATIENT: All singleton infants whose parents were living in the city of Marseilles, France, between 2013 and 2016. METHOD: Population-based study based on new-born hospital birth admission charts from the French National Uniform Hospital Discharge Data Set Database. LGA infants were compared to appropriate-for-gestational-age (AGA) infants. Multiple generalized logistic model analysis was used to examine factors associated with LGA. RESULTS: A total of 43,309 singleton infants were included, and 4,747 (11%) were born LGA. LGA infants were more likely to have metabolic and respiratory diseases and to be admitted to the neonatal intensive care unit. Multiparity, advanced maternal age, obesity and diabetes were associated with an increased risk of LGA. Lower neighbourhood SES was associated with LGA (aOR = 1.24, 95% CI: 1.14; 1.36; p<0.0001) independent of age, diabetes, obesity, maternal smoking and multiparity. The strength of this association increased with maternal age, reaching an aOR of 1.50 (95% CI: 1.26; 1.78; p<0.0001) for women > 35 years old. CONCLUSION: Neighbourhood SES could be considered an important factor for clinicians to better identify mothers at risk of having LGA births in addition to well-known risk factors such as maternal diabetes, obesity and age. The intensification of the association between SES and LGA with increasing maternal age suggests that neighbourhood disadvantage may act on LGA cumulatively over time.


Assuntos
Peso ao Nascer/fisiologia , Macrossomia Fetal/etiologia , Classe Social , Adulto , Índice de Massa Corporal , Diabetes Gestacional , Feminino , Macrossomia Fetal/economia , França , Idade Gestacional , Humanos , Lactente , Recém-Nascido , Masculino , Mães , Obesidade/complicações , Paridade , Gravidez , Complicações na Gravidez , Fatores de Risco , Fatores Socioeconômicos , Aumento de Peso/fisiologia
7.
J Clin Invest ; 130(5): 2644-2656, 2020 05 01.
Artigo em Inglês | MEDLINE | ID: mdl-32310225

RESUMO

We previously established that global deletion of the enhancer of trithorax and polycomb (ETP) gene, Asxl2, prevents weight gain. Because proinflammatory macrophages recruited to adipose tissue are central to the metabolic complications of obesity, we explored the role of ASXL2 in myeloid lineage cells. Unexpectedly, mice without Asxl2 only in myeloid cells (Asxl2ΔLysM) were completely resistant to diet-induced weight gain and metabolically normal despite increased food intake, comparable activity, and equivalent fecal fat. Asxl2ΔLysM mice resisted HFD-induced adipose tissue macrophage infiltration and inflammatory cytokine gene expression. Energy expenditure and brown adipose tissue metabolism in Asxl2ΔLysM mice were protected from the suppressive effects of HFD, a phenomenon associated with relatively increased catecholamines likely due to their suppressed degradation by macrophages. White adipose tissue of HFD-fed Asxl2ΔLysM mice also exhibited none of the pathological remodeling extant in their control counterparts. Suppression of macrophage Asxl2 expression, via nanoparticle-based siRNA delivery, prevented HFD-induced obesity. Thus, ASXL2 controlled the response of macrophages to dietary factors to regulate metabolic homeostasis, suggesting modulation of the cells' inflammatory phenotype may impact obesity and its complications.


Assuntos
Metabolismo Energético , Células Mieloides/metabolismo , Obesidade/prevenção & controle , Proteínas Repressoras/deficiência , Tecido Adiposo Marrom/metabolismo , Tecido Adiposo Marrom/patologia , Tecido Adiposo Branco/metabolismo , Tecido Adiposo Branco/patologia , Animais , Dieta Hiperlipídica/efeitos adversos , Feminino , Técnicas de Silenciamento de Genes , Inflamação/metabolismo , Inflamação/patologia , Macrófagos/metabolismo , Macrófagos/patologia , Masculino , Camundongos , Camundongos Endogâmicos C57BL , Camundongos Knockout , Células Mieloides/patologia , Obesidade/metabolismo , Obesidade/patologia , Especificidade de Órgãos , RNA Interferente Pequeno/genética , Proteínas Repressoras/genética , Proteínas Repressoras/metabolismo , Aumento de Peso/genética , Aumento de Peso/fisiologia
8.
Respir Physiol Neurobiol ; 273: 103332, 2020 02.
Artigo em Inglês | MEDLINE | ID: mdl-31628989

RESUMO

BACKGROUND AND OBJECTIVE: Body weight of patients with obstructive sleep apnea after initiation of nasal continuous positive airway pressure appears to increase. We hypothesized that intermittent hypoxia (IH) will decrease energy expenditure (EE), and that normoxic recovery will lead to body weight gains. METHODS: C57BL/6 J male mice were exposed to either 12 h/day of mild IH (alternating FIO2-10-11% and 21%; 640 s cycle), or severe IH (FIO2-6-7%-21%; 180 s cycle) or sham IH daily for 4 or 8 weeks. After exposures, EE was evaluated while mice were kept under normoxia for 5 weeks and organ histology was evaluated. RESULTS: EE was not decreased by IH. However, visceral white adipocyte size after normoxic recovery was significantly increased in severe IH in an intensity-dependent manner. CONCLUSION: Our hypothesis that IH would decrease EE was not corroborated. However, IH and normoxic recovery seem to promote severity-dependent enlargement of visceral adipocytes, likely reflecting altered energy preservation mechanisms induced by IH.


Assuntos
Adipócitos Brancos/metabolismo , Pressão Positiva Contínua nas Vias Aéreas , Metabolismo Energético/fisiologia , Hipóxia/metabolismo , Gordura Intra-Abdominal/metabolismo , Apneia Obstrutiva do Sono/metabolismo , Aumento de Peso/fisiologia , Animais , Pressão Positiva Contínua nas Vias Aéreas/efeitos adversos , Modelos Animais de Doenças , Masculino , Camundongos , Camundongos Endogâmicos C57BL
9.
RMD Open ; 5(2): e001009, 2019.
Artigo em Inglês | MEDLINE | ID: mdl-31798952

RESUMO

Decreased mineral density is one of the major complications of anorexia nervosa. The phenomenon is even more pronounced when the disease occurs during adolescence and when the duration of amenorrhoea is long. The mechanisms underlying bone loss in anorexia are complex. Oestrogen deficiency has long been considered as the main factor, but cannot explain the phenomenon on its own. The essential role of nutrition-related factors-especially leptin and adiponectin-has been reported in recent studies. Therapeutic strategies to mitigate bone involvement in anorexia are still a matter for debate. Although resumption of menses and weight recovery appear to be essential, they are not always accompanied by a total reversal of bone loss. There are no studies in the literature demonstrating that oestrogen treatment is effective, and the best results seem to have been obtained with agents that induce bone formation-such as IGF-1-especially when associated with oestrogen. As such, bone management in anorexia remains difficult, hence, the importance of early detection and multidisciplinary follow-up.


Assuntos
Amenorreia/complicações , Anorexia Nervosa/complicações , Densidade Óssea/fisiologia , Osteoporose/terapia , Absorciometria de Fóton , Adiponectina/administração & dosagem , Adiponectina/deficiência , Amenorreia/metabolismo , Anorexia Nervosa/diagnóstico , Anorexia Nervosa/metabolismo , Anorexia Nervosa/reabilitação , Densidade Óssea/efeitos dos fármacos , Conservadores da Densidade Óssea/administração & dosagem , Quimioterapia Combinada , Estrogênios/administração & dosagem , Estrogênios/metabolismo , Exercício Físico/fisiologia , Feminino , Humanos , Fator de Crescimento Insulin-Like I/administração & dosagem , Leptina/administração & dosagem , Leptina/deficiência , Lipólise/efeitos dos fármacos , Osteoporose/diagnóstico , Osteoporose/etiologia , Osteoporose/metabolismo , Proteínas Recombinantes/administração & dosagem , Resultado do Tratamento , Aumento de Peso/fisiologia
10.
BMC Res Notes ; 12(1): 624, 2019 Sep 23.
Artigo em Inglês | MEDLINE | ID: mdl-31547854

RESUMO

OBJECTIVES: To investigate the relationship between longitudinal weight-change and objectively-measured physical activity (PA) in a rural African setting in 143 adults (≥ 30 years), using data from two cross-sectional surveys, separated by approximately 10 years. Participants were categorised into three weight-change groups (Weight-loss: ≥ 25 kg m-2→ < 25 kg m-2; Weight-gain: < 25 kg m-2→ ≥ 25 kg m-2; Weight-stability: remained < 25 kg m-2 or ≥ 25 kg m-2). Daily ambulation and activity energy expenditure (AEE), measured in the 2005-2007 health survey, was examined across the weight-change groups. Using the daily AEE data, the proportion of those in the weight-change groups, meeting or not meeting two PA guidelines (150- and 420 min week-1), was examined. RESULTS: Weight-change was found in 18.2% of the sample. There was no significant overall body mass change (+ 1.2 kg, p = 0.1616). However, there was significant change in body mass in the weight-gain (+ 15.2 kg) and weight-loss (- 10.8 kg) groups (p ≤ 0.0011). Nearly 90% of those who gained weight met the 150 min week-1 guideline. A significantly greater proportion of the weight-stable group (< 25 kg m-2) met the 420 min week-1 guideline (p < 0.05). Ambulatory level was high irrespective of weight group, although the weight-stable group (< 25 kg m-2) approached 15,000 steps day-1. There was an inconsistent and weak association between PA and weight-change in this group.


Assuntos
Metabolismo Energético/fisiologia , Exercício Físico/fisiologia , Atividade Motora/fisiologia , Aumento de Peso/fisiologia , Redução de Peso/fisiologia , Acelerometria , Adulto , Idoso , Antropometria , Composição Corporal , Índice de Massa Corporal , Estudos Transversais , Feminino , Política de Saúde/legislação & jurisprudência , Humanos , Masculino , Pessoa de Meia-Idade , População Rural , África do Sul
11.
Psychoneuroendocrinology ; 110: 104423, 2019 12.
Artigo em Inglês | MEDLINE | ID: mdl-31487568

RESUMO

Maximising infant survival requires secure attachments and appropriate behaviours between parents and offspring. Oxytocin is vital for parent-offspring bonding and behaviour. It also modulates energetic balance and neural pathways regulating feeding. However, to date the connections between these two areas of the hormone's functionality are poorly defined. We demonstrate that grey seal (Halichoerus grypus) mothers with high oxytocin levels produce pups with high oxytocin levels throughout lactation, and show for the first time a link between endogenous infant oxytocin levels and rates of mass gain prior to weaning. High oxytocin infants gained mass at a greater rate without additional energetic cost to their mothers. Increased mass gain in infants was not due to increased nursing, and there was no link between maternal mass loss rates and plasma oxytocin concentrations. Increased mass gain rates within high oxytocin infants may be due to changes in individual behaviour and energy expenditure or oxytocin impacting on tissue formation. Infancy is a crucial time for growth and development, and our findings connect the oxytocin driven mechanisms for parent-infant bonding with the energetics underlying parental care. Our study demonstrates that oxytocin release may connect optimal parental or social environments with direct physiological advantages for individual development.


Assuntos
Animais Lactentes , Metabolismo Energético/fisiologia , Ocitocina/sangue , Focas Verdadeiras , Aumento de Peso/fisiologia , Animais , Animais Lactentes/sangue , Animais Lactentes/crescimento & desenvolvimento , Feminino , Lactação/fisiologia , Masculino , Comportamento Materno/fisiologia , Mães , Focas Verdadeiras/crescimento & desenvolvimento , Focas Verdadeiras/metabolismo , Desmame
12.
J Obstet Gynaecol Res ; 45(8): 1536-1544, 2019 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-31161703

RESUMO

AIM: To establish a model predicting successful vaginal delivery (VD) in nulliparas with term cephalic singleton pregnancies. METHODS: We retrospectively identified 6799 term nulliparas with cephalic singletons (6416 VD and 383 cesarean section [CS] due to dystocia) who entered labor (cervical dilation ≥2 cm) between September 2014 and August 2015. Using VD as the dependent variable and age, maternal body height, educational attainment, gravidity, gestational age, pre-pregnancy body mass index (BMI), BMI upon admission for delivery, gestational weight gain, gestational hypertension and gestational diabetes as the independent variables, predictors of VD success were identified using a multivariate binary logistic regression and then ranked with decision-tree analysis. RESULTS: While multiple factors are associated with improved VD success, we found body height, gestational age, and intrapartum BMI to be the best predictors of successful VD. Our predictive model has a classification accuracy, sensitivity and specificity of 76.6%, 96.7% and 16.4%, respectively, and it was subsequently confirmed by both internal and external validation. CONCLUSION: Our predictive model indicates body height, gestational age and intrapartum BMI as the major predictors of successful VD in low-risk patients.


Assuntos
Estatura/fisiologia , Índice de Massa Corporal , Tomada de Decisão Clínica , Árvores de Decisões , Parto Obstétrico/estatística & dados numéricos , Idade Gestacional , Modelos Biológicos , Adulto , Peso Corporal/fisiologia , Cesárea/estatística & dados numéricos , Feminino , Humanos , Paridade , Reprodutibilidade dos Testes , Estudos Retrospectivos , Sensibilidade e Especificidade , Aumento de Peso/fisiologia
13.
J Med Internet Res ; 21(5): e12201, 2019 05 17.
Artigo em Inglês | MEDLINE | ID: mdl-31102373

RESUMO

BACKGROUND: Obesity is one of the largest drivers of health care spending but nearly half of the population with obesity demonstrate suboptimal readiness for weight loss treatment. Black women are disproportionately likely to have both obesity and limited weight loss readiness. However, they have been shown to be receptive to strategies that prevent weight gain. OBJECTIVE: The aim of this study was to evaluate the costs and cost-effectiveness of a digital weight gain prevention intervention (Shape) for black women. Shape consisted of adaptive telephone-based coaching by health system personnel, a tailored skills training curriculum, and patient self-monitoring delivered via a fully automated interactive voice response system. METHODS: A cost and cost-effectiveness analysis based on a randomized clinical trial of the Shape intervention was conducted from the payer perspective. Costs included those of delivering the program to 91 intervention participants in the trial and were summarized by program elements: self-monitoring, skills training, coaching, and administration. Effectiveness was measured in quality-adjusted life years (QALYs). The primary outcome was the incremental cost per QALY of Shape relative to usual care. RESULTS: Shape cost an average of US $758 per participant. The base-case model in which quality of life benefits decay linearly to zero 5 years post intervention cessation, generated an incremental cost-effectiveness ratio (ICER) of US $55,264 per QALY. Probabilistic sensitivity analyses suggest an ICER below US $50,000 per QALY and US $100,000 per QALY in 39% and 98% of simulations, respectively. Results are highly sensitive to durability of benefits, rising to US $165,730 if benefits end 6 months post intervention. CONCLUSIONS: Results suggest that the Shape intervention is cost-effective based on established benchmarks, indicating that it can be a part of a successful strategy to address the nation's growing obesity epidemic in low-income at-risk communities.


Assuntos
Terapia Comportamental/economia , Terapia Comportamental/métodos , Análise Custo-Benefício/métodos , Qualidade de Vida/psicologia , Aumento de Peso/fisiologia , Feminino , Humanos , Masculino , Atenção Primária à Saúde
14.
J Endocrinol ; 242(2): R1-R8, 2019 08.
Artigo em Inglês | MEDLINE | ID: mdl-31042668

RESUMO

Short-chain fatty acids (SCFAs) are metabolites produced from the fermentation of dietary fibre by the gut microbiota. High-fibre diets have been associated with lower weight gain and a number of reports have therefore investigated if these positive effects of a dietary fibre on body weight can be replicated through the direct administration of SCFAs. Many of these studies have reported that SCFAs can prevent or attenuate long-term body weight gain by increasing energy expenditure through increased lipid oxidation. The aim of the present review is to therefore evaluate the current evidence for an effect of SCFAs on whole-body energy expenditure and to assess the potential underlying mechanisms. The available data highlights that SCFAs can exert multiple effects at various organ and tissue sites that would cumulatively raise energy expenditure via a promotion of lipid oxidation. In conclusion, the present review proposes that dietary interventions and other therapies that augment gut-derived SCFAs and systemic availability may present an effective strategy to improve long-term energy balance and body weight management.


Assuntos
Fibras na Dieta/metabolismo , Metabolismo Energético/fisiologia , Ácidos Graxos Voláteis/metabolismo , Microbioma Gastrointestinal/fisiologia , Animais , Peso Corporal/fisiologia , Humanos , Metabolismo dos Lipídeos/fisiologia , Oxirredução , Aumento de Peso/fisiologia
15.
Child Obes ; 15(5): 306-312, 2019 07.
Artigo em Inglês | MEDLINE | ID: mdl-31058538

RESUMO

Background: Childhood obesity is a recognized public health concern worldwide. It is essential to study the natural progression of obesity in the interest of prevention. This study aimed to describe the dynamic changes in weight status among elementary school children and identify the significant factors influencing the progression or regression of weight status. Methods: This study involved 928 elementary school children who were followed up annually during their elementary school years. Heights, weights, and vital capacity (VC) were measured each school year. A multistate Markov model containing three weight states was fit to longitudinal weight status data. Results: Children with healthy weight and obesity tended to stay in their preceding weight state. Children with overweight, in contrast, were more likely to move to the other two states. The mean sojourn time in obesity and in overweight states was 5.15 years (95% confidence interval [CI]: 4.22-6.3) and 2 years (95% CI: 1.76-2.28), respectively. Children in lower grades, those with a lower VC index, those with a higher initial BMI, those with a higher annual weight increment, and boys were at increased risk of progression to overweight or obesity, with a decreased probability of regression. Conclusions: Children with obesity were more resistant to recovery than those with overweight. Prevention and intervention measures should be adopted early when abnormal weight onset occurs. The multistate Markov model was an advanced tool to analyze dynamic changes in status and identify significant factors for progression and regression and helped to develop prevention and intervention targeting strategies.


Assuntos
Peso Corporal/fisiologia , Obesidade Infantil/epidemiologia , Estatura/fisiologia , Criança , Feminino , Humanos , Estudos Longitudinais , Masculino , Cadeias de Markov , Estudantes/estatística & dados numéricos , Capacidade Vital/fisiologia , Aumento de Peso/fisiologia
16.
BMC Psychiatry ; 19(1): 114, 2019 04 16.
Artigo em Inglês | MEDLINE | ID: mdl-30991969

RESUMO

BACKGROUND: With previously established efficacy of aripiprazole once-monthly injectable formulation (AOM) in pre-registration randomized controlled trials, the current study was designed to evaluate its effectiveness in patients treated for schizophrenia in regular clinical settings in Canada. METHODS: Following their clinicians' decision to prescribe AOM, 193 patients with a diagnosis of schizophrenia, were recruited from 17 Canadian community or hospital-based settings. The primary outcome of global functioning was assessed with the Global Assessment of Functioning Scale (GAF) at 3-month intervals for 1 year. Secondary outcomes (social and occupational functioning and illness severity) and adverse drug reactions (ADR) were also assessed. RESULTS: A majority of the 169 evaluable patients were within the first 5 years of diagnosis (early phase). A linear mixed model analysis showed a significant main effect of time (Type III test p < 0.001) after adjusting for baseline GAF score, with a change in mean GAF scores from 49 at baseline to 61 at 12 months. No differences between early vs late phase were observed. Results on secondary outcome measures of function (Social and Occupational Functioning Scale) and illness severity (Clinical Global Impression-Severity Scale and Brief Psychiatric Rating Scale) were similar. Serious ADRs were observed in 29 (14.6%) patients and akathisia in 18 (9.1%) patients. At month-12, significant (≥7%) weight gain was observed in 25.7% (n = 27/105) of patients. CONCLUSIONS: Treatment with AOM is effective in improving symptoms and functioning in schizophrenia patients treated in regular clinical settings. Akathisia was infrequent while one quarter of patients gained clinically significant weight. TRIAL REGISTRATION: Unique identifier: NCT02131415 . First posted: 06 May 2014.


Assuntos
Antipsicóticos/administração & dosagem , Aripiprazol/administração & dosagem , Esquizofrenia/tratamento farmacológico , Esquizofrenia/epidemiologia , Psicologia do Esquizofrênico , Adolescente , Adulto , Antipsicóticos/efeitos adversos , Aripiprazol/efeitos adversos , Escalas de Graduação Psiquiátrica Breve , Canadá/epidemiologia , Estudos de Coortes , Esquema de Medicação , Feminino , Seguimentos , Humanos , Masculino , Pessoa de Meia-Idade , Estudos Prospectivos , Esquizofrenia/diagnóstico , Resultado do Tratamento , Aumento de Peso/efeitos dos fármacos , Aumento de Peso/fisiologia , Adulto Jovem
17.
Obesity (Silver Spring) ; 27(4): 535-541, 2019 04.
Artigo em Inglês | MEDLINE | ID: mdl-30900408

RESUMO

OBJECTIVE: This study aimed to assess the efficacy of a home-based lifestyle intervention delivered through Parents as Teachers (PAT), a national home-visiting organization, designed to minimize excessive weight gain through 12 months post partum in socioeconomically disadvantaged (SED) African American women with overweight or obesity. METHODS: This randomized controlled trial was conducted at a single center as part of the Lifestyle Interventions for Expectant Moms (LIFE-Moms) consortium. Analysis was conducted with 185 SED African American women (BMI 25.0-45.0 kg/m2 at pregnancy onset) retained from an original sample of 267 randomized to standard PAT or PAT+Lifestyle, which embedded lifestyle therapy within standard PAT delivered prenatally and for 12 months post partum. RESULTS: Compared with standard PAT, the PAT+Lifestyle group gained less weight (2.5 kg vs. 5.7 kg; P = 0.01) and were more likely to return to their baseline weight (38.0% vs. 21.5%; P = 0.01) from baseline to 12 months post partum. There were no differences between groups in cardiometabolic outcomes, indices of glycemic control and insulin sensitivity, and plasma lipid profile. The estimated cost of PAT+Lifestyle was $81 more to deliver per family than standard PAT. CONCLUSIONS: PAT+Lifestyle decreases weight gain during pregnancy through 12 months post partum in SED African American women with overweight or obesity at the start of pregnancy with minimal additional cost.


Assuntos
Terapia Comportamental/métodos , Obesidade/terapia , Sobrepeso/terapia , Cuidado Pós-Natal/métodos , Transtornos Puerperais/terapia , Populações Vulneráveis , Aumento de Peso , Adolescente , Adulto , Negro ou Afro-Americano , Terapia Comportamental/economia , Glicemia , Peso Corporal , Feminino , Serviços de Assistência Domiciliar , Humanos , Estilo de Vida , Pessoa de Meia-Idade , Período Pós-Parto/fisiologia , Gravidez , Complicações na Gravidez/terapia , Populações Vulneráveis/estatística & dados numéricos , Aumento de Peso/fisiologia , Adulto Jovem
18.
Nutrients ; 11(3)2019 Mar 24.
Artigo em Inglês | MEDLINE | ID: mdl-30909642

RESUMO

The aim of this study was to assess the association between amount (below or above recommendations), preparation (liquid vs. powder), and type (regular vs. hydrolysate) of infant formula consumed and weight in infants participating in the Women, Infant and Children (WIC) Program in Hawaii (HI) and Puerto Rico (PR). This was a secondary analysis of 162 caregivers with healthy term 0⁻2-month-old infants. Socio-demographics, infant food frequency questionnaires, and weight and length were assessed at baseline and after four months. Infant feeding practices were associated with weight-for-length z-scores using multivariable logistic regression. In total, 37.7% were exclusively breastfed and 27.2% were exclusively formula-fed. Among formula users, regular (63.6%) and powder (87.0%) formula were the most common; 43.2% consumed formula above recommendations. Most infants had rapid weight gain (61.1%). Infants fed regular formula had higher odds of overweight after four months (adjusted OR = 8.77, 95% CI: 1.81⁻42.6) and higher odds of rapid weight gain (adjusted OR = 3.10, 95% CI: 1.12, 8.61). Those exclusively formula fed had higher odds of slow weight gain (adjusted OR = 4.07, 95% CI: 1.17⁻14.2). Formula preparation and amount of formula were not associated with weight. These results could inform the WIC program's nutrition education messages on infant feeding. Studies with longer follow-up are needed to confirm these results.


Assuntos
Ingestão de Alimentos/fisiologia , Comportamento Alimentar/fisiologia , Fórmulas Infantis/análise , Aumento de Peso/fisiologia , Peso Corporal/fisiologia , Aleitamento Materno/estatística & dados numéricos , Inquéritos sobre Dietas , Feminino , Assistência Alimentar , Havaí , Humanos , Lactente , Fenômenos Fisiológicos da Nutrição do Lactente , Recém-Nascido , Modelos Logísticos , Masculino , Análise Multivariada , Sobrepeso/etiologia , Porto Rico
19.
J Clin Endocrinol Metab ; 104(7): 2648-2656, 2019 07 01.
Artigo em Inglês | MEDLINE | ID: mdl-30753542

RESUMO

BACKGROUND: Evidence suggests that metabolic adaptation occurs after bariatric surgery such that resting energy expenditure (REE) declines more than accounted for by body weight or body composition changes in adults. Little is known about REE and metabolic adaptation among adolescents after bariatric surgery. OBJECTIVE: To examine changes in REE and metabolic adaptation among adolescents at 12 months (12M) after bariatric surgery. SETTING: Pediatric hospital, Canada. METHODS: Adolescents undergoing Roux-en-Y gastric bypass (RYGB) or sleeve gastrectomy (SG) were followed. Bioelectrical impedance analysis and indirect calorimetry were completed to measure body composition and REE, respectively. Predicted REE was calculated using the Mifflin equation before and after bariatric surgery and a predictive equation using preoperative data. RESULTS: Among 20 patients (15 girls), the mean age and body mass index at surgery were 17.2 ± 0.8 years and 48.7 ± 7.4 kg/m2, respectively. REE had decreased by 548.3 kcal/d at 12M postoperatively (P < 0.001). Metabolic adaptation, determined by two procedures, was negative and significantly different from baseline (P < 0.05). When stratified by surgery type, REE change at 12M was not significantly different (RYGB, -494.0 ± 260.9 kcal/d, n = 11; SG, -614.6 ± 344.4 kcal/d, n = 9; P = 0.384). Among 13 patients with REE data at 6 and 12M, no statistically significant difference was found (P = 0.368). CONCLUSIONS: Predicted and measured REE was 19% and 25% lower at 12M, respectively, irrespective of bariatric surgery type. Metabolic adaptation might predispose adolescents to weight regain after bariatric surgery and warrants careful nutritional management and counseling.


Assuntos
Adaptação Fisiológica , Cirurgia Bariátrica/métodos , Metabolismo Energético/fisiologia , Obesidade Mórbida/cirurgia , Obesidade Infantil/cirurgia , Aumento de Peso/fisiologia , Adolescente , Composição Corporal/fisiologia , Feminino , Seguimentos , Humanos , Masculino , Obesidade Mórbida/metabolismo , Obesidade Infantil/metabolismo , Período Pós-Operatório , Descanso/fisiologia , Resultado do Tratamento , Redução de Peso/fisiologia , Adulto Jovem
20.
Int J Obes (Lond) ; 43(3): 603-614, 2019 03.
Artigo em Inglês | MEDLINE | ID: mdl-30283079

RESUMO

OBJECTIVES: This study examines the prospective association between sugar-sweetened beverages (SSB) consumption and change in body weight over a 4-5-year period in a socio-economically disadvantaged South African population. METHODS: This is a longitudinal study involving 800 adults (212 men, 588 women); 247 from the original METS (Modelling the Epidemiological Transition Study) cohort (N = 504) and 553 of the original 949 members of the PURE (Prospective Urban and Rural Epidemiology) Study. Both cohorts were drawn from low-income, socio-economically disadvantaged communities. Mean follow-up duration and age were 4.5 (SD 0.45) and 50.0 (SD 11.8) years, respectively. Harmonised measurements included body mass index, self-reported moderate-to-vigorous physical activity, and intake of meat, snacks and 'take-aways', fruits and vegetables and SSB (in servings/week). Multivariate logistic regression models were developed to determine the extent to which SSB consumption predicted relative weight gain, after controlling for potential confounders and known predictors. RESULTS: Nearly a third (29%) of participants had a relative weight change ≥5.0%; higher in the non-obese compared to the obese group (32% vs. 25%; p = 0.026). The average SSB consumption was 9.9 servings/week and was higher in the food insecure compared to the food secure group (11.5 vs. 9.0 servings/week; p = 0.006); but there were no differences between women and men (10.3 vs. 9.1 servings/week; p = 0.054). Mean SSB consumption was higher in the group who gained ≥5% weight compared to those who did not (11.0 vs. 8.7; p = 0.004). After adjustment, SSB consumption of 10 or more servings/week was associated with a 50% greater odds of gaining at least 5% body weight (AOR: 1.50, 95% CI (1.05-2.18)). CONCLUSION: These results show that higher intake of SSB predicts weight gain in a sample of South Africans drawn from low-income settings. Comprehensive, population-wide interventions are needed to reduce SSB consumption in these settings.


Assuntos
Dieta/estatística & dados numéricos , Bebidas Adoçadas com Açúcar/estatística & dados numéricos , Aumento de Peso/fisiologia , Adulto , Feminino , Abastecimento de Alimentos/estatística & dados numéricos , Humanos , Estudos Longitudinais , Masculino , Pessoa de Meia-Idade , Pobreza , África do Sul/epidemiologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA